289 related articles for article (PubMed ID: 33810567)
21. EJ-ras oncogene transfection of endothelial cells upregulates the expression of syndecan-4 and downregulates heparan sulfate sulfotransferases and epimerase.
Lopes CC; Toma L; Pinhal MA; Porcionatto MA; Sogayar MC; Dietrich CP; Nader HB
Biochimie; 2006 Oct; 88(10):1493-504. PubMed ID: 16793191
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin-like growth factor receptor in the expression of cell surface heparan sulfate proteoglycans and cell motility in breast cancer cells.
Tsonis AI; Afratis N; Gialeli C; Ellina MI; Piperigkou Z; Skandalis SS; Theocharis AD; Tzanakakis GN; Karamanos NK
FEBS J; 2013 May; 280(10):2248-59. PubMed ID: 23374155
[TBL] [Abstract][Full Text] [Related]
23. Syndecan-4 influences mammalian myoblast proliferation by modulating myostatin signalling and G1/S transition.
Keller-Pinter A; Szabo K; Kocsis T; Deak F; Ocsovszki I; Zvara A; Puskas L; Szilak L; Dux L
FEBS Lett; 2018 Sep; 592(18):3139-3151. PubMed ID: 30129974
[TBL] [Abstract][Full Text] [Related]
24. Expression of the proteoglycan syndecan-4 and the mechanism by which it mediates stress fiber formation in folliculostellate cells in the rat anterior pituitary gland.
Horiguchi K; Kouki T; Fujiwara K; Tsukada T; Ly F; Kikuchi M; Yashiro T
J Endocrinol; 2012 Aug; 214(2):199-206. PubMed ID: 22645300
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA regulation of proteoglycan function in cancer.
Ibrahim SA; Hassan H; Götte M
FEBS J; 2014 Nov; 281(22):5009-22. PubMed ID: 25168226
[TBL] [Abstract][Full Text] [Related]
26. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
27. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract][Full Text] [Related]
28. Transforming Growth Factor-β
Hara T; Yoshida E; Fujiwara Y; Yamamoto C; Kaji T
J Cell Biochem; 2017 Aug; 118(8):2009-2017. PubMed ID: 28019669
[TBL] [Abstract][Full Text] [Related]
29. Syndecan-4 contributes to endothelial tubulogenesis through interactions with two motifs inside the pro-angiogenic N-terminal domain of thrombospondin-1.
Nunes SS; Outeiro-Bernstein MA; Juliano L; Vardiero F; Nader HB; Woods A; Legrand C; Morandi V
J Cell Physiol; 2008 Mar; 214(3):828-37. PubMed ID: 17879962
[TBL] [Abstract][Full Text] [Related]
30. PR-39 coordinates changes in vascular smooth muscle cell adhesive strength and locomotion by modulating cell surface heparan sulfate-matrix interactions.
Chon JH; Houston MM; Xu C; Chaikof EL
J Cell Physiol; 2001 Nov; 189(2):133-43. PubMed ID: 11598898
[TBL] [Abstract][Full Text] [Related]
31. Expression and characterization of minican, a recombinant syndecan-1 with extensively truncated core protein.
Viklund L; Loo BM; Hermonen J; El-Darwish K; Jalkanen M; Salmivirta M
Biochem Biophys Res Commun; 2002 Jan; 290(1):146-52. PubMed ID: 11779146
[TBL] [Abstract][Full Text] [Related]
32. Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.
Poças J; Marques C; Gomes C; Otake AH; Pinto F; Ferreira M; Silva T; Faria-Ramos I; Matos R; Ribeiro AR; Senra E; Cavadas B; Batista S; Maia J; Macedo JA; Lima L; Afonso LP; Ferreira JA; Santos LL; Polónia A; Osório H; Belting M; Reis CA; Costa-Silva B; Magalhães A
Proc Natl Acad Sci U S A; 2023 May; 120(20):e2214853120. PubMed ID: 37155874
[TBL] [Abstract][Full Text] [Related]
33. Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases.
Lim HC; Couchman JR
Biochim Biophys Acta; 2014 Aug; 1840(8):2482-90. PubMed ID: 24447566
[TBL] [Abstract][Full Text] [Related]
34. Syndecan-1 (CD138) as a Pathogenesis Factor and Therapeutic Target in Breast Cancer.
Sheta M; Götte M
Curr Med Chem; 2021; 28(25):5066-5083. PubMed ID: 34191695
[TBL] [Abstract][Full Text] [Related]
35. Syndecan-2 regulates the migratory potential of melanoma cells.
Lee JH; Park H; Chung H; Choi S; Kim Y; Yoo H; Kim TY; Hann HJ; Seong I; Kim J; Kang KG; Han IO; Oh ES
J Biol Chem; 2009 Oct; 284(40):27167-75. PubMed ID: 19641225
[TBL] [Abstract][Full Text] [Related]
36. Glycan Sulfation Modulates Dendritic Cell Biology and Tumor Growth.
El Ghazal R; Yin X; Johns SC; Swanson L; Macal M; Ghosh P; Zuniga EI; Fuster MM
Neoplasia; 2016 May; 18(5):294-306. PubMed ID: 27237321
[TBL] [Abstract][Full Text] [Related]
37. A unique phenylalanine in the transmembrane domain strengthens homodimerization of the syndecan-2 transmembrane domain and functionally regulates syndecan-2.
Kwon MJ; Choi Y; Yun JH; Lee W; Han IO; Oh ES
J Biol Chem; 2015 Feb; 290(9):5772-82. PubMed ID: 25572401
[TBL] [Abstract][Full Text] [Related]
38. The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP).
Mathiesen SB; Lunde M; Aronsen JM; Romaine A; Kaupang A; Martinsen M; de Souza GA; Nyman TA; Sjaastad I; Christensen G; Carlson CR
J Biol Chem; 2019 May; 294(22):8717-8731. PubMed ID: 30967474
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components.
Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ
J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035
[TBL] [Abstract][Full Text] [Related]
40. Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling.
Bass MD; Humphries MJ
Biochem J; 2002 Nov; 368(Pt 1):1-15. PubMed ID: 12241528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
